Edward and Pearl Fein Memory and Aging Center Lecture Series

Alzheimer's Disease Biomarkers Across Diverse Communities – Findings from the HABS-HD Study

Sid O'Bryant, PhD
Executive Director, Institute for Translational Research
‌Dr. Joe and Peggy Schooler Endowed Chair in Pharmacology and Neuroscience
UNT Health Fort Worth

Learning Objectives

• Analyze key Alzheimer's disease biomarkers identified across diverse populations in the HABS-HD study and their implications for diagnosis and disease progression.
• Evaluate how findings from the HABS-HD study can inform more equitable, culturally responsive, and precision-based approaches to Alzheimer's disease research and care.

Disclosures

• Planners: Bruce L. Miller, MD; Howard J. Rosen, MD; Anil Vora; and Laura Wise have stated they have no relationships to disclose.
• Speaker: Sid O'Bryant, PhD, has stated he has no relationships to disclose.

Accreditation: The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation: UCSF designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit is inclusive of all Edward and Pearl Fein Memory and Aging Center Grand Rounds sessions offered from January 1, 2026, through December 31, 2026. (1 credit per each 1-hour grand rounds session throughout the year).

Virtual attendees must register for this event. Grand Rounds presentations are for educational purposes and intended for a professional audience with a terminal degree. This activity is not commercially supported.